title: [Rivaroxaban at least as effective as marcumar in stroke prevention].
authors.forename: Jochen
authors.initials: J
authors.lastname: Aumiller
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D002544:Cerebral Infarction / Q000097:blood / Q000517:prevention & control*; D004311:Double-Blind Method; D006801:Humans; D019934:International Normalized Ratio; D009025:Morpholines / Q000009:adverse effects / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D010644:Phenprocoumon / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D000069552:Rivaroxaban; D055502:Secondary Prevention; D020521:Stroke / Q000097:blood / Q000517:prevention & control*; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban; D010644:Phenprocoumon